Basic information
Biomarker: Cathepsin-B
Histology type: endometrial carcinoma
Cohort characteristics
Country: Greece
Region: Athens
Followed up time :
Subgroup 1 name : positive
Subgroup 1 number: 27
Subgroup 2 name: negative
Subgroup 2 number: 37
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
64 | EC | 64 |
Sample information
Conclusion: Increased Cathepsin-B expression was found to be predictive of more aggressive tumour behaviour over time and can be regarded as an unfavourable and independent tumour marker for endometrial cancer patients with a long follow-up.
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : expression
Expression elevation: The immunoreactivity intensity was evaluated as absent; very fine, diffuse cytoplasmic staining from the cytoplasm towards the cell membrane (+); moderate cytoplasmic staining of intermediate level (++); more coarse cytoplasmic staining that stains the cell membrane and parts of the extra-cellular area (+++). Reproducibility of the scoring method used by both observers was greater than 95%. For each slide, a value designated HSCORE was obtained by application of the following algorithm: HSCORE =Σ[(i+ 1) × PC], where i and PC represent intensity and percentage of cells that stain at each intensity, respectively
Disease information
Related information
Funtion Uniprot: Thiol protease which is believed to participate in intracellular degradation and turnover of proteins (PubMed:12220505). Cleaves matrix extracellular phosphoglycoprotein MEPE (PubMed:12220505). Involved in the solubilization of cross-linked TG/thyroglobulin in the thyroid follicle lumen (By similarity). Has also been implicated in tumor invasion and metastasis (PubMed:3972105).
UniProt ID: P07858
UniProt Link: https://www.uniprot.org/uniprotkb/P07858/entry
Molecular function from UniProt:
Tissue specificity from UniProt: Expressed in the stratum spinosum of the epidermis. Weak expression is detected in the stratum granulosum.
Subcellular UniProt: #Cell membrane #Lysosome #Membrane #Secreted
Alternative name from UniProt:
Cleaved: Cleaved into 2 chains Cathepsin B light chain Cathepsin B heavy chain
Catalytic activity: Hydrolysis of proteins with broad specificity for peptide bonds. Preferentially cleaves -Arg-Arg-|-Xaa bonds in small molecule substrates (thus differing from cathepsin L). In addition to being an endopeptidase, shows peptidyl-dipeptidase activity, liberating C-terminal dipeptides.
Recommended name: Cathepsin B
Gene name from HGNC: CTSB
HPA class: Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Human disease related genes Metabolic proteins Plasma proteins Potential drug targets
AlphaFold DB: P07858
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P07858
HPA link: https://www.proteinatlas.org/ENSG00000164733-CTSB
Tissue specificity RNA from HPA: Low tissue specificity
Tissue expression from HPA: General granular cytoplasmic expression.
Single cell type specificity Cell type enhanced (Hofbauer cells, Kupffer cells, Macrophages)
Immune cell specificity: Group enriched (classical monocyte, intermediate monocyte, plasmacytoid DC, basophil, non-classical monocyte, myeloid DC)
Subcellular summary HPA Located in Nucleoli, Vesicles (Single cell variability)
Cancer prognostic summary HPA Prognostic marker in thyroid cancer (favorable) and urothelial cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000164733-CTSB/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000164733-CTSB/pathology/endometrial+cancer
Phenotype ID: 148370
Disease: Keratolytic winter erythema (KWE)
Note1: The gene represented in this entry is involved in disease pathogenesis. Tandem duplications in a non-coding genomic region containing an active enhancer element for CTSB result in CTSB abnormal expression with pathological consequences
Note2: A number sign (#) is used with this entry because of evidence that keratolytic winter erythema (KWE) is caused by heterozygous duplication in a cis-acting regulatory element enhancer upstream of the CTSB gene (116810) on chromosome 8p23.
OMIM: 116810;148370;
OMIM link1: https://www.omim.org/entry/148370
OMIM link2: https://www.omim.org/entry/116810;https://www.omim.org/entry/148370;
Phenotype: KERATOLYTIC WINTER ERYTHEMA
HGNC ID: HGNC:2527
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:2527